サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542594

レッドバイオテクノロジーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Red Biotechnology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
レッドバイオテクノロジーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レッドバイオテクノロジー市場の世界需要は、2023年の6,047億2,000万米ドルから2032年には1兆5,393億9,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは10.94%です。

医療バイオテクノロジーとしても知られるレッドバイオテクノロジーは、医薬品、医療機器、診断、医療ソリューションに焦点を当てたバイオテクノロジーの一セグメントです。グリーンバイオテクノロジー（農業バイオテクノロジー）やホワイトバイオテクノロジー（産業バイオテクノロジー）とは異なり、主に医療医療用途を対象としています。生物学的プロセス、生物、システムを利用して、疾病の診断、予防、治療、医療全般の改善を目的とした製品や技術を開発します。

市場力学

世界のレッドバイオテクノロジー市場は、慢性疾患や感染症の世界の蔓延の高まりに牽引され、著しい成長を遂げています。レッドバイオテクノロジーは、がん、糖尿病、心血管障害、COVID-19のような感染症に関連する医療の課題に対処するための革新的な治療法、ワクチン、診断ツールの開発において極めて重要です。さらに、ゲノム研究、個別化医療、バイオ医薬品の進歩が市場の成長を促進しています。遺伝子編集、組換えDNA技術、モノクローナル抗体などの治療技術は、医療への標的を絞ったカスタマイズ型アプローチを可能にし、治療効果と患者の転帰を向上させる。

さらに、製薬会社、学術機関、政府組織による研究開発（R&D）への投資の増加が、レッドバイオテクノロジーの技術革新を促進しています。こうした投資は、新薬候補の発見、疾病診断のためのバイオマーカー、バイオテクノロジーの進歩を活用した画期的な治療法の発見を支えています。学術界、産業界、医療プロバイダー間の共同研究は、科学的発見を臨床応用に結びつけるための学際的研究努力を促進します。しかし、バイオ医薬品や医療技術革新の実現に伴う高コストと長い開発期間、規制上の課題、バイオテクノロジー製品の厳しい承認プロセスが、市場成長の課題となっています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはレッドバイオテクノロジーの世界市場における各セグメントを包括的に評価することもできます。レッドバイオテクノロジー産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

レッドバイオテクノロジー市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家が今後のビジネス機会とともに、それぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカのレッドバイオテクノロジー市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 レッドバイオテクノロジー-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 レッドバイオテクノロジーの世界市場分析：製品別

  • 製品別概要
  • 製品別過去・予測データ分析
  • モノクローナル抗体
  • ポリクローナル抗体
  • 組み換えタンパク質
  • ワクチン
  • 細胞ベースの免疫療法製品
  • 遺伝子治療製品
  • 細胞治療製品
  • 組織工学製品
  • 幹細胞
  • 細胞培養
  • ウイルスベクター
  • 酵素
  • キットと試薬
  • 動物モデル
  • 分子診断薬
  • その他

第6章 レッドバイオテクノロジーの世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 学術研究機関
  • CMOとCRO
  • 製薬・バイオテクノロジー企業
  • その他

第7章 世界のレッドバイオテクノロジー市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第8章 レッドバイオテクノロジー企業の競合情勢

  • レッドバイオテクノロジー市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Merck KGaA
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • AstraZeneca Plc
  • Takeda Pharmaceutical Company Limited
  • Gilead Sciences
  • Biogen Inc.
  • Amgen Inc.
  • Celgene Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Polyclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Cell-Based Immunotherapy Products Market Sales By Geography (USD MN)
  • Gene Therapy Products Market Sales By Geography (USD MN)
  • Cell Therapy Products Market Sales By Geography (USD MN)
  • Tissue-Engineered Products Market Sales By Geography (USD MN)
  • Stem Cells Market Sales By Geography (USD MN)
  • Cell Culture Market Sales By Geography (USD MN)
  • Viral Vector Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Kits and Reagents Market Sales By Geography (USD MN)
  • Animal models Market Sales By Geography (USD MN)
  • Molecular diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • CMOs & CROs Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Red Biotechnology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Red Biotechnology Report
  • Market Research Process
  • Market Research Methodology
  • Global Red Biotechnology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Polyclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Cell-Based Immunotherapy Products Market Sales By Geography (USD MN)
  • Gene Therapy Products Market Sales By Geography (USD MN)
  • Cell Therapy Products Market Sales By Geography (USD MN)
  • Tissue-Engineered Products Market Sales By Geography (USD MN)
  • Stem Cells Market Sales By Geography (USD MN)
  • Cell Culture Market Sales By Geography (USD MN)
  • Viral Vector Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Kits and Reagents Market Sales By Geography (USD MN)
  • Animal models Market Sales By Geography (USD MN)
  • Molecular diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Academic Research Institutes Market Sales By Geography (USD MN)
  • CMOs & CROs Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219534

The global demand for Red Biotechnology Market is presumed to reach the market size of nearly USD 1539.39 Billion by 2032 from USD 604.72 Billion in 2023 with a CAGR of 10.94% under the study period 2024-2032.

Red biotechnology, also known as medical biotechnology, is a branch of biotechnology focused on pharmaceuticals, medical devices, diagnostics, and healthcare solutions. Unlike green biotechnology (agricultural biotechnology) and white biotechnology (industrial biotechnology), it primarily targets medical and healthcare applications. It involves using biological processes, organisms, or systems to develop products and technologies to diagnose, prevent, and treat diseases and improve overall healthcare outcomes.

MARKET DYNAMICS

The global red biotechnology market is witnessing significant growth driven by the rising prevalence of chronic and infectious diseases worldwide. Red biotechnology is crucial in developing innovative therapies, vaccines, and diagnostic tools to address healthcare challenges associated with cancer, diabetes, cardiovascular disorders, and infectious diseases like COVID-19. Moreover, advancements in genomic research, personalized medicine, and biopharmaceuticals are fuelling market growth. Technologies such as gene editing, recombinant DNA technology, and monoclonal antibodies enable targeted and customized approaches to healthcare, enhancing treatment efficacy and patient outcomes.

Furthermore, increasing investments in research & development (R&D) by pharmaceutical companies, academic institutions, and government organizations drive innovation in red biotechnology. These investments support the discovery of novel drug candidates, biomarkers for disease diagnosis, and breakthrough therapies that leverage biotechnological advancements. Collaborations between academia, industry, and healthcare providers foster interdisciplinary research efforts to translate scientific discoveries into clinical applications. However, the high cost and lengthy development timelines associated with bringing biopharmaceuticals and medical innovations, regulatory challenges & stringent approval processes for biotechnological products pose a challenge to market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Red Biotechnology. The growth and trends of Red Biotechnology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Red Biotechnology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Stem Cells
  • Cell Culture
  • Viral Vector
  • Enzymes
  • Kits and Reagents
  • Animal models
  • Molecular diagnostics
  • Others

By End-User

  • Academic Research Institutes
  • CMOs & CROs
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Red Biotechnology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Red Biotechnology market include Merck KGaA, F. Hoffmann-La Roche AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., AstraZeneca Plc, Takeda Pharmaceutical Company Limited, Gilead Sciences, Biogen Inc., Amgen Inc., Celgene Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. RED BIOTECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-User
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 5.4. Polyclonal Antibodies Historic and Forecast Sales By Regions
  • 5.5. Recombinant Proteins Historic and Forecast Sales By Regions
  • 5.6. Vaccines Historic and Forecast Sales By Regions
  • 5.7. Cell-Based Immunotherapy Products Historic and Forecast Sales By Regions
  • 5.8. Gene Therapy Products Historic and Forecast Sales By Regions
  • 5.9. Cell Therapy Products Historic and Forecast Sales By Regions
  • 5.10. Tissue-Engineered Products Historic and Forecast Sales By Regions
  • 5.11. Stem Cells Historic and Forecast Sales By Regions
  • 5.12. Cell Culture Historic and Forecast Sales By Regions
  • 5.13. Viral Vector Historic and Forecast Sales By Regions
  • 5.14. Enzymes Historic and Forecast Sales By Regions
  • 5.15. Kits and Reagents Historic and Forecast Sales By Regions
  • 5.16. Animal models Historic and Forecast Sales By Regions
  • 5.17. Molecular diagnostics Historic and Forecast Sales By Regions
  • 5.18. Others Historic and Forecast Sales By Regions

6. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY END-USER

  • 6.1. Overview By End-User
  • 6.2. Historical and Forecast Data Analysis By End-User
  • 6.3. Academic Research Institutes Historic and Forecast Sales By Regions
  • 6.4. CMOs & CROs Historic and Forecast Sales By Regions
  • 6.5. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL RED BIOTECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RED BIOTECHNOLOGY COMPANIES

  • 8.1. Red Biotechnology Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF RED BIOTECHNOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Merck KGaA
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. F. Hoffmann-La Roche AG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Pfizer Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Regeneron Pharmaceuticals Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. AstraZeneca Plc
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Takeda Pharmaceutical Company Limited
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Gilead Sciences
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Biogen Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Amgen Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Celgene Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies